🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 19 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 15/05/2018 | 105,60 | 108,11 | 105,01 | 107,05 | +0,46% | 2,94% | 429.700 |
| 14/05/2018 | 103,32 | 106,72 | 103,32 | 106,56 | +3,56% | 3,29% | 301.400 |
| 11/05/2018 | 101,63 | 103,50 | 100,57 | 102,90 | +1,74% | 2,88% | 357.800 |
| 10/05/2018 | 102,87 | 103,28 | 100,64 | 101,14 | -2,29% | 2,57% | 339.600 |
| 09/05/2018 | 102,24 | 103,94 | 101,05 | 103,51 | +1,55% | 2,83% | 369.900 |
| 08/05/2018 | 103,74 | 103,76 | 101,46 | 101,93 | -0,46% | 2,22% | 551.800 |
| 07/05/2018 | 102,99 | 104,36 | 101,81 | 102,40 | -0,56% | 2,48% | 299.800 |
| 04/05/2018 | 102,02 | 103,80 | 101,18 | 102,98 | +0,61% | 2,57% | 385.800 |
| 03/05/2018 | 102,97 | 105,54 | 100,76 | 102,36 | -1,87% | 4,64% | 454.200 |
| 02/05/2018 | 112,65 | 112,98 | 101,99 | 104,31 | -6,59% | 9,76% | 892.900 |
| 01/05/2018 | 110,33 | 112,23 | 108,90 | 111,67 | +1,42% | 3,02% | 353.100 |
| 30/04/2018 | 110,88 | 112,81 | 109,46 | 110,11 | -0,26% | 3,02% | 450.700 |
| 27/04/2018 | 110,64 | 111,94 | 108,82 | 110,40 | -0,42% | 2,82% | 235.700 |
| 26/04/2018 | 110,60 | 112,44 | 109,94 | 110,87 | +1,00% | 2,26% | 243.200 |
| 25/04/2018 | 110,11 | 111,35 | 108,33 | 109,77 | -0,25% | 2,74% | 273.500 |
| 24/04/2018 | 111,34 | 111,88 | 108,61 | 110,05 | -1,30% | 2,94% | 288.600 |
| 23/04/2018 | 114,25 | 114,80 | 110,51 | 111,50 | -2,24% | 3,75% | 343.400 |
| 20/04/2018 | 113,13 | 114,82 | 112,19 | 114,06 | +0,95% | 2,32% | 501.400 |
| 19/04/2018 | 112,09 | 115,11 | 111,53 | 112,99 | +0,71% | 3,19% | 304.100 |
| 18/04/2018 | 113,94 | 115,58 | 110,86 | 112,19 | -1,67% | 4,14% | 553.600 |
| 17/04/2018 | 113,69 | 115,69 | 112,04 | 114,09 | +1,07% | 3,21% | 326.600 |
| 16/04/2018 | 113,06 | 114,23 | 111,90 | 112,88 | +0,36% | 2,06% | 293.500 |
| 13/04/2018 | 111,61 | 114,10 | 111,09 | 112,47 | +1,51% | 2,70% | 304.600 |
| 12/04/2018 | 112,79 | 113,12 | 110,29 | 110,80 | -1,78% | 2,51% | 277.000 |
| 11/04/2018 | 111,56 | 114,01 | 111,56 | 112,81 | +0,75% | 2,20% | 382.900 |
| 10/04/2018 | 112,15 | 112,50 | 109,66 | 111,97 | +1,44% | 2,53% | 347.000 |
| 09/04/2018 | 111,67 | 112,12 | 109,24 | 110,38 | +0,11% | 2,58% | 445.300 |
| 06/04/2018 | 112,09 | 113,30 | 109,69 | 110,26 | -2,45% | 3,22% | 345.300 |
| 05/04/2018 | 117,50 | 118,93 | 112,49 | 113,03 | -2,85% | 5,48% | 404.400 |
| 04/04/2018 | 113,81 | 116,50 | 112,53 | 116,34 | +0,49% | 3,49% | 515.300 |